政策动向 国家卫健委：保障重点地区、重要时间节点血液供应 6月12日，国家卫生健康委举行新闻发布会，介绍无偿献血及血费减免一次都不跑有关情况。 国家卫生健康委医疗应急司副司长、一级巡视员高光明介绍，近两年来，受多方面因素影响，全球无偿 献血出现下降趋势。我国受人口老龄化进程加速、人民生活方式转变以及宣传组织动员等多种因素叠加 影响，血液供需矛盾仍较明显，临床用血需求不断提升，季节性、地区性、偏型性血液紧张仍然存在。 2024年全国无偿献血量同比有所下降。针对上述情况，国家卫生健康委采取多种举措保障血液安全供 应。 其中，健全全国血液联动应急保障能力，精准开展跨区域血液调配，保障重点地区、重要时间节点的血 液供应。2024年全国累计调配血液361.3万单位，其中省际间共调配血液58.3万单位，同比增长35.1%。 及时解决季节性、区域性、偏型性血液保障问题。 药械审批 科伦药业：注射用头孢唑林钠/氯化钠注射液获得药品注册批准 6月12日，科伦药业(002422.SZ)公告称，公司子公司湖南科伦制药有限公司的化学药品"注射用头孢唑 林钠/氯化钠注射液"于近日获得国家药品监督管理局的药品注册批准。该药品为粉液双室袋 ...

Syndax Pharmaceuticals (SNDX) FY Conference June 11, 2025 02:00 PM ET Speaker0 Good afternoon, everyone. Thanks for joining us here at Goldman Sachs Senior Healthcare Conference. Thrilled to be joined by the team from Maybe I'll kick it off. I'll let you guys introduce yourselves and then introduce the company. Speaker1 Sure. Good to see you, Corinne. Thank you. I'm Michael Metzger. I'm the CEO of Syndax, I've been with the company about ten years. And to my left, Steve? Yes. Steve Kloster, our Speaker2 Chi ...

Journey Medical Corp (DERM) Q1 2025 Earnings Call May 14, 2025 04:30 PM ET Speaker0 Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's First Quarter twenty twenty five Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen only mode. Participants of this call are advised that the audio of this conference call is being broadcast live I would now like to turn the call over to Jacqueline Jaffe, the company's Senior D ...

Journey Medical Corp (DERM) Q4 2024 Earnings Call March 26, 2025 04:30 PM ET Company Participants Jaclyn Jaffe - Senior Director of Corporate OperationsClaude Maraoui - Co-Founder, President and Chief Executive OfficerJoseph Benesch - CFOLouis Donati - Director - Market AccessSrinivas Sidgiddi - Vice President - Research & DevelopmentBrandon Folkes - Managing Director - Equity Research Conference Call Participants Thomas Flaten - Senior Research AnalystScott Henry - Managing Director & Senior Research Analy ...